Airway Management in COVID-19 as Aerosol Generating Procedure by Shallik, Nabil A. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Airway Management in COVID-19
as Aerosol Generating Procedure
Nabil A. Shallik, Muhammad Firas Khader Alhammad,
Yasser Mahmoud Hammad Ali Hammad, Elfert Amr,
Shakeel Moideen and Mashael Abdulrahman M.S. Al Khelaifi
Abstract
2020 has seen the whole world battling a pandemic. Coronavirus Disease 2019
(COVID-19) is primarily transmitted through respiratory droplets when in close
contact with an infected person, by direct contact, or by contact with contaminated
objects and surfaces. Aerosol generating procedures (AGPs) like intubation have a
high chance of generating large concentrations of infectious aerosols. AGPs poten-
tially put healthcare workers at an increased risk of contracting the infection, and
therefore special precautions are necessary during intubation. The procedure has to
be performed by an expert operator who uses appropriate personal protective
equipment (PPE). Modifications of known techniques have helped to reduce the
chances of contracting the infection from patients. The use of checklists has become
standard safe practice. This chapter looks at the current knowledge we have
regarding this illness and how we should modify our practice to make managing the
airway both safer for the patient and the healthcare workers involved. It addresses
the preparation, staff protection, technical aspects and aftercare of patients who
need airway intervention. It recommends simulation training to familiarize staff
with modifications to routine airway management.
Keywords: coronavirus, airway management, intubation, covid 19, novel virus,
aerosol generating procedures
1. Introduction
The current outbreak of the novel coronavirus (Severe Acute Respiratory Syn-
drome Coronavirus 2 – SARS CoV-2) (COVID-19) was first reported as a cluster of
pneumonia cases on Dec 31st, 2019 from Wuhan, Hubei province, China. The
World Health Organization (WHO) declared COVID-19 as a public health emer-
gency of international concern (PHEIC) on Jan 30th, 2020, and on March 11th,
2020 WHO characterized the spread of coronavirus as a pandemic.
We know that COVID-19 is primarily spread through respiratory droplets when
in close contact with an infected person, or by contact with contaminated objects
and surfaces. This puts healthcare workers attending to an infective patient at risk
of contracting the illness, and airway management, being an AGP, would be the
riskiest of all interventions. AGPs like intubation have a high chance of generating
large concentrations of infectious aerosols. Therefore, special precautions are nec-
essary during intubation. The procedure has to be performed by an expert operator
1
who uses personal protective equipment (PPE) such as FFP3 or N95 masks, protec-
tive goggles, disposable long sleeved gowns, disposable double gloves and leg cov-
erings. It is important to recognize mask ventilation and open suctioning of airways
as AGPs. If possible, thorough preoxygenation and a rapid sequence induction and
intubation (RSII) should be performed. Heat and moisture exchanger (HME) must
be positioned between the mask and the breathing circuit or between the mask and
the ventilation balloon. Personnel involved in the room should be kept to a mini-
mum and this should be decided beforehand. Small changes to what we know as
conventional airway management has been studied and improved upon to keep
both COVID 19 patients and staff looking after them safe. This chapter looks at the
details inside operating theater and kindly note that the airway management of
COVID 19 patient in Intensive care settings are discussed in much details in other
chapter in this book.
2. Epidemiology
Corona virus pandemic has evolved since December 2019 in Wuhan, China.
Starting from Wuhan the novel virus named Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) invaded all the over the globe [1], causing corona
virus disease 2019 (COVID 19) [2]. As of July 2020, infected cases are increasing
incredibly around the world. Based on current real-time reports, the estimated
infected cases is fifteen million cases reported and more than 610.000 deaths
worldwide [3]. The number of infected cases is expected to increase as the second
peak is rising in most countries.
3. Transmission
COVID19 pandemic started as an outbreak in Wuhan with mainly transmission
from animal to human. This theory was raised after most primarily infected people
had visited or worked in seafood the market at Wuhan [4], and later on person to
person transmission has been identified [5].
It is well known today that corona virus transmission is established by droplet.
This is simply droplets with size 5–10 micron that can carry the virus. However till
there is now no clear evidence to support airborne transmission (droplets size less
than 5 micron which can carry the virus and able to remain in air for a period of
time) but considering that this is still possible, the recommendation is to manage
aerosols generating procedures as highly contaminating [6]. Experimental studies
have revealed that the virus can be detected on different surfaces after these sur-
faces are exposed to the virus between 4 hours to 3 days depending on the surface
type, the virus is more stable on plastic and stainless-steel surfaces [7].
4. Airway assessment
Airway assessment is recommended whenever there is airway management.
Generally speaking the evidence behind airway assessment does not show high
specificity nor sensitivity except for previous difficult intubation history, COVID 19
patients mostly need urgent or emergent interventions i.e. intubation. In these
circumstances’ airway evaluation is not always practical It is worth mentioning that
most of these patients are critically ill. COVID 19 is known to cause laryngitis and
upper airway oedema is not uncommon in this population which could make
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intubation challenging [8]. In COVID 19 patient’s general recommendation for
airway assessment will apply when it is possible and unanticipated difficult airway
should be kept in mind.
COVID 19 patients are critically ill which preclude standard airway assessment.
The difficult airway is defined as:
The difficult airway is “the clinical situation in which a conventionally trained
anaesthesiologist experiences difficulty with facemask ventilation, difficulty in
supraglottic device ventilation, difficulty in tracheal intubation or all three” [9].
4.1 Steps for airway assessment
History: previous difficult intubation history, last meal, previous critical events,
smoking, drooling, dysphagia, recent burn in face or upper respiratory system, head
or neck trauma, OSA, snoring hoarse voice stridor.
Physical examination: mouth, face, neck, teeth, Mallampati score.
Investigations: X-Ray, USG (ultrasonography), CT, MRI, nasal endoscopy, 3D &
Virtual Endoscopy (VE), can be used for airway assessment.
Many score systems and tools have been developed to predict difficult airway;
useful tools might be used like:
The 6 D methods (Table 1): [10], LEMON score system (Table 2) [11]
MMMMASK mnemonics (Table 3), or OBESE mnemonics (Table 4). (please
refer to other book’s chapters for more details).
The most important recommendation for health care provider who will take a
history or will do examination of the airway of suspected or infected COVID 19, is
to wear full PPE to protect himself or herself from the infection.
5. Personal protection and optimal environment
Health care workers (HCW) are at a high risk to be infected with SARS-COV-2
(COVID 19) in particular during any aerosol generating procedures. As discussed
before the main transmission route appears to be by respiratory droplets and con-
tact transmission. Not surprisingly these droplets have very high virus load [13]. In
view of this protecting personnel who are managing airways in COVID 19 patients
must be at the most priority. Aerosol generating procedures vary in their ability to
infect HCW but intubation tracheostomy, non-invasive ventilation (NIV) and bag
mask ventilation (BMV) appear to carry the highest risk [14].
All efforts should be made to protect HCW providing airway management this
will include many aspects to keep in mind. We can summarize them as following:
• Full PPE (personal protective equipment)
• Surface decontamination
• Equipment decontamination
• Negative pressure room
• Minimizing health care workers during active procedure
• Waste management
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Sign of difficulty Description Quantitative or qualitative
findings







1. Disproportion • Increased size of
tongue in relation
to pharyngeal size
• Mallampati class III or IV • Mallampati
class I or II












• Tracheal deviation • No
contractures
of the neck
• Neck asymmetry • No surgical
airway scar
2. Distortion • Neck mass • Voice changes • Mobile
laryngeal
anatomy









in the neck joints
• Nonpalpable thyroid cartilage
Previous surgical
airway







>7 cm (~3 finger breadths)
measured from the superior aspect













• Distance between upper and lower
incisors (i.e., inter-incisor gap)
<4 cm (<2 finger breadths)
• Mandibular condyle fracture





5. Decreased range of
motion in any or all of
























• Neck flexion <35° • Cervical spine
flexion ≥35°
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Sign of difficulty Description Quantitative or qualitative
findings










• Short, thick neck • Long, thin
neck













• Dental overbite • No dental
overbite
Table 1.






















N Neck mobility 1
Table 2.
Shows LEMON score for airway assessment [12].
MMMMASK Description
M Male gender
M Mask seal which is affected by bread or being edentulous
M Mallampati grade 3or4
M Mandibular
A Age
S Snoring and OSA
K Kilograms (weight)
Table 3.
Shows MMMMASK mnemonics difficult airway.
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It is well known today that use of full PPE reduces the risk of infection in corona
virus family [15], Based on retrospective study published on March 2020, hospital
acquired infection was 41.3% from those 29% were health care workers from dif-
ferent specialties [16].
Level 3 (enhanced) is recommended in COVID 19 suspected or confirmed cases
airway management for better understanding it is worth to mention here in sum-
mary what are the level of PERSONAL protection for healthcare workers [17]
(Table 5).
The person who is performing the intubation should wear a third pair of gloves
and remove them immediately after intubation [18].
Minimizing number of people during intubation is preferred in order to reduce
risk of exposure. The interval time after intubation should be taken into consider-
ation. The required waiting period will vary between 15 and 30 minutes [19].
OBESE Description




E Elderly (>55 years)
Table 4.
Shows OBESE mnemonics for difficult mask ventilation.
Level 1 SICPs Standard Infection Control Precaution
• Disposable apron
• Disposable gloves
Level 2 CONTACT DIRECT/INDIRECT CONTACT PRECAUTIONS
• Fluid-resistant disposable gown
• Disposable gloves
Level 2 DROPLET DROPLET (RESPIRATORY) PRECAUTIONS
• Fluid-resistant disposable gown
• Disposable gloves
• Fluid-resistant Type IIR surgical face mask and goggle or visor
Level 2 AIRBORNE AIRBORNE (RESPIRATORY) PRECAUTIONS
• Fluid resistant disposable gown
• disposable gloves
• Filtering face piece 3 (FFP3) respirator and eye protection




• Reinforced fluid-resistant long-sleeved surgical gown
• Disposable fluid-resistant hood (if wearing a gown without an attached
hood)
• Full length disposable plastic apron
• FFP3 respirator or powered hood respirator
• Disposable full-face visor
• 2 sets of long or extended cuff non-sterile, non-latex disposable gloves
• Surgical wellington boots or closed shoes
• Disposable boot covers
Table 5.
Levels of personal protective equipment (PPE) for healthcare workers when providing patient care. (copied
from health protection Scotland, “levels of personal protective equipment (PPE) for ward patient care”).
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Negative pressure rooms with good rates of air exchange (> 12 exchanges per
hour) is recommended to minimize risk of airborne exposure, in case not available
portable HEPA filters or negative air flow, can be considered to reduce risk.
It is very important to have a clear plan for the airway management team. The
plan should be discussed in detail with clarifying the rescue one in case unantici-
pated difficult airway management appear.
Staff who should avoid involvement in airway management: Immunocompro-
mised or pregnant health care workers are advised not enroll in airway
management for COVID 19 patients. Also, HCW above age of 60 years old mortal-
ity curve will increase remarkably in COVID 19 and patients with cardiac disease
chronic respiratory disease; diabetes; recent cancer; and perhaps hypertension
that is why it is recommended to exclude HCW who have any of these
co-morbidities [20].
6. Non-invasive methods of ventilation in aerosol generating procedure
6.1 Nasal cannula
Low-flow nasal oxygen (nasal cannula) may provide some oxygenation during
apnoea (apnoeic oxygenation) and might therefore delay or reduce the extent of
hypoxemia during tracheal intubation [21] however, literature suggests this benefi-
cial effect might be worthless in patients with primary respiratory failure like in
COVID 19 patients [22] Till now, there is no evidence that low flow nasal canula can
generate aerosols, in COVID 19 patients so, it is not recommended to use it rou-
tinely during intubation [23].
6.1.1 High flow nasal cannula
Using high flow nasal cannula (HFNC) 30–70 L/min significantly increases the
risk of spreading exhaled gas [24], debate around using HFNC in COVID 19 con-
sidering it prolong apnoea time remarkably however there is few predisposed dis-
advantage: when used in deteriorating patients it is delaying intubation in severely
ill patients who really need intubation, exhausting hospital oxygen reserves as a
results in very high demand [25], when used during intubation risk of generating
aerosol that carrying the virus [26].
Important note: after a few hours of ventilation by high flow nasal cannula
(HFNC), the oropharyngeal airway and trachea become extremely dry, due to a
high oxygen flow reaching 60 L/min. Which leads to difficulty in passing the
endotracheal tube (ETT). So, make sure that the tube and the intubation equipment
are very well lubricated to allow the tube to go easily through the vocal cords. Our
personal experience is to soak the pharyngeal cavity with 10 ml 0.9% saline and
some gel to allow a sufficient lubrication for this purpose.
6.1.2 Non-invasive ventilation
Data regarding use of non-invasive ventilation (NIV) in COVID 19 patients
is limited but based on recent systematic review published recently the evidence
for using NIV in COVID 19 patient is currently low in quality however it
might reduce mortality and increase risk of healthcare worker transmission [27].
Many centres recommend to use NIV in view of limited resources in pandemic
regions or using hyperbaric oxygen therapy in preventing mechanical ventilation in
COVID-19 in other centers [28–30].
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Endotracheal intubation is considered a very high-risk procedure in COVID 19
patients. For many reasons usually COVID 19 patients who need intubation
urgently are critically ill patients with severe hypoxemia and respiratory failure.
Desaturation is very quick because of depleted oxygen reserve and high consump-
tion with regards to severe inflammatory status also involvement of other organ
failure makes airway management of these cases are challenging. Special attention
to the previous mentioned points may provide avoidance of major complications
and avoidable deaths ensuring the safety of healthcare workers involved. Sever
hypoxemia during ICU intubation has been reported in 25% [31]. In general, phys-
iologically and anatomically airway management in critically ill patients consider
challenging.
7.2 Before intubation
All equipment should be prepared with tracheal intubation checklist (see -
Figure 1) [32] and preferably COVID 19 airway intubation trolley to be prepared
figure [33], medications should be prepared in advance, crash trolley should be
handy before progress to intubation.
7.2.1 Communication
In operating theater or in ICU setting delegated person, an outside-room “run-
ner” to provide additional outside-room equipment and medications.
The runner can communicate with the inside personnel using special pager or
phone kept inside water seal cover.
Figure 1.
Checking list an example of emergency intubation checklist from safe airway society [34].
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Optimizing communication: wearing full PPE make communication is really
difficult so it is very important to use clear language with loud voice repeating the
order to make sure communication is efficient. As recognizing a person with full
PPE is somewhat difficult so, it is recommended to put sticker with individual name
on top of visor [35].
7.2.2 Virus filters
Using of heat moisture exchanger (HME filter) has been advised by many
centers which can filter the viruses including Corona virus by 99 percent. HME
filter should be attached most proximal to patient i.e. directly to ETT or between the
mask and bag of Ambu, another alternative to HME filter that can be used is high
efficiency particulate air filter (HEPA filter). Another HME filter is kept between
expiratory limb of anesthesia circuit and anesthesia machine (Figure 2).
7.2.3 Video laryngoscope
In covid 19 pandamic Video laryngoscopy is recommended as first line option
for airway management the rational be [44]:
Higher chance for ETT pass first attempt, reducing chance of infection for the
intubator by increasing the distance between the patient airway and the incubators
face also use of special drapes is possible and might increase the level of protection,
better intubation view can be achieved especially in full PPE situation where the
face shield and googles (with fog) are obstructing clear view.
Two pieces of video laryngoscope (display, single use probe) are better to be
used to make sure the intubator’s face is far away from the patient’s mouth during
the procedure [36] in addition, first pass success rate is much higher in experienced
manager with video laryngoscope than direct laryngoscope.
7.2.4 Pre-oxygenation
Preoxygenation is crucial part before intubating covid 19 patients as these
patients are ill and prone to very rapid desaturation due to the nature of the disease.
When it is possible 3–5 minutes of preoxygenation is recommended using non
rebreathing mask with 10–15 liter/O2 which provide 100% Fio2, if NRM is not
enough modified non invasive ventilation might needed with close circuit and
HEPA filter. If bagging the patient is inventible for preoxygenation this should be
done with two hand technique with HEPA filter however avoiding bagging the
patient is always recommended when it is possible [38].
Ideally pre-oxygenation could avoid necessity of bag mask ventilation but there
is no guarantee especially in critical COVID 19 patients.
Figure 2.
Ventilation circuits setup (image courtesy Dr. Nabil Shallik).
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Keeping the patient in 45 degree (reverse Trendelenburg positioning)may help
in increasing apnea time improving the preoxygenation .
7.2.5 Fibroscopic intubation
Flexible bronchoscope can be used in anticipated difficult airway however, it is
not advised to be used routinely. But if you in real need in difficult case, better to
shift to single use fibro scope [37].
7.3 During intubation
Endotracheal Tube (ETT) confirmation site should be confirmed by ETCO2
because full PPE will make auscultation much difficult and using stethoscope
impractical. Clinically observing chest rising may help in precluding unilateral
intubation. Also seeing the ETT passing through vocal cord and recording using
video laryngoscopic screen is the best way of confirmation of endotracheal
intubation.
As most of COVID 19 patients who need mechanical ventilation will have ARDS
so, lung protective mechanical ventilation strategies should be used (target tidal
volume less than 6 mLkg  1 predicted body weight, plateau pressure ≤ 30 cm
H20, target SaO2 88–95% and pH ≥ 7.25 [38].
The most experience intubator should perform the intubation in order to achieve
high first pass success [39] and reduce the contamination and the intubator should
use a technique which he is familiar and comfortable with.
Many of novel devices have been introduced trying to achieve high level of
protection during the intubation procedure itself, like novel intubation plastic box
and plastic cover. Yet there is no definite evidence that such these devices could
really protect the intubator from the aerosols [40], few articles suggested that and
current studies are ongoing to prove it.
One of the common novel devices recently introduced is intubation novel box.
First time had been described by Dr. Lai Hsien-yung [41], The device composed of a
transparent plastic cube covering a patient’s head and shoulders, with access holes
for the intubating procedure and additional hole for an assistance. These device
have been discussed in medical literature [42]but more commonly on social media
and medical education websites, often being praised for their ingenuity (Figure 3).
Brown et al., has created “Barrier System for Airway Management of COVID-19
Patients” it is simply a plastic drape attached to a plastic bag as a protective measure
during end tracheal intubation and extubation [43].
7.4 Some tips and tricks during intubation
• Modified Rapid Sequence Induction and Intubation (RSII) is advised as it
reduces the time to intubation as securing the airway, with or without cricoid
pressure. Drugs of choice are discussed later [44]
• Bag mask ventilation should be minimized unless there it is indicated
3–5 minutes of pre-oxygenation with 100% will help.
• Optimizing the patient position for intubation is recommended as any other
intubation tool as video-laryngoscope will be used straight line head which
suppose make the intubation more convenient, in obese patient ramping
position is recommended.
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• In cardiovascular instability induction agents should be chosen carefully for the
best hemodynamic stability i.e. (Ketamine, Etomidate).
• Regardless of the choice of induction agents, ensure that the patient is deep
enough before starting intubation to prevent coughing and straining during
intubation and this will lead to aerosolization of organisms.
• As RSII is recommended, the rapid acting muscle relaxant should be used in a
good dose to ensure complete relaxation that the patient will not cough for
example (Succinylcholine 1.5 mg/kg, Rocuronium1.2 mg/kg).
• As many patients could have severe hypotension, loaded vasopressors should
be immediately available for bolus or infusion. Phenylephrine, Ephedrine can
be used as a first line.
• Some experts recommended Continuous Positive Airway Pressure (CPAP)
with good sealing as this might help to delay desaturation with apneic
oxygenation, using proper size oral airway after induction will help in
maintaining the airway patency. If CPAP is not enough to prevent
desaturation, then bag-mask ventilation should start with two hand technique
and minimal oxygen flow and minimal airway pressure. (Figure 4)
• While video-laryngoscope is the best option to start yet using adjunctive is
pretty helpful for C-MAC Macintosh blade and C-MAC D-blade (Karle Storz,
Germany); it is a good idea to use Gum Elastic Bougie (GEB) in case needed.
Also, stylet can be used to ease intubation with GlideScope (Verathon, Burnby,
Figure 3.
Plastic intubation box (image courtesy Dr. Nabil Shallik).
11
Airway Management in COVID-19 as Aerosol Generating Procedure
DOI: http://dx.doi.org/10.5772/intechopen.96889
BC, Canada). If video laryngoscope is not available for any reason direct
laryngoscopy could be other option using Macintosh blade with Gum Elastic
Bougie (GEB) help.
• Tube size should be reliable with patient condition and should be the biggest
diameter size that fit the patient preferably supplied with subglottic suction
port.
• After tube insertion under direct vision, inflate the ETT cuff between 20–30
cmH2O then connect the circuit provided by HME/HEPA filter, anesthesia
machine or mechanical ventilator should be in standby mode at this point, after
making sure the ETT cuff is inflated well, we can start mechanical ventilation.
Waiting for capnography waveform to confirm correct tube site and observing
chest movement as mentioned before.
• Please note that auscultation is not practical with full PPE and difficult to
perform so, we have to rely on other parameters. Airway pressure can help the
intubator or heath care provider to figure out a bronchial intubation as well as
circuit leak. The reason of not using auscultation is not the impractibal
procedure, the reason is not to increase the contamination risk)
• During intubation if suction needed it is advised to use close loop suction, in
line catheter suction.
• Some procedure will increase the risk of circuit disconnection or ETT
displacement so, attention during these procedures must be taken to avoid any
complication and contamination: examples of these procedures are patient
proning, nasogastric tube insertion, Trans Esophageal Echocardiography
(TEE) procedure, or oral suctioning.
• For ultimate reducing possible contamination during ventilation It is
recommended by safe airway society to arrange the circuit in this order, i.e.
keep the ETCO2 sample line always distal
Figure 4.
(√): Two-handed two-person bag-mask technique with the VE hand position; the second person squeezes the
bag. (X): The CE hand position, which should be avoided. (image courtesy Dr. Nabil Shallik).
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• to the patient.
• Difficult airway management:
Difficulty can happen in many aspects:
1.Facemask ventilation is not adequate,
2.Placement of a supraglottic airway (SGA) is difficult,
3.Laryngoscopy and tracheal intubation: inability to intubate the patient.
4.Same consideration for non- COVID patients will be applied in COVID19
patients, nevertheless the reason of difficulty, the crucial part is to have a
pre-prepared plan and being well ready in order to avoid any serious
complications.
5.COVID 19 intubation trolley should be ready.
6.The cause of difficult airway actually is multifactorial including the effect of
patient factors, the clinical setting, and the skills of the practitioner.
7.There are many local institutional policies and algorithm to manage
anticipated and unanticipated difficult airway. (Figure 5).
Declare the status clearly to team members is very important, in case FONA
needed the recommended technique is the one to minimize aerosol generating
Figure 5.
(a) Tracheal intubation adapted for COVID 19 patient & (b) CICO adapted for COVID 19 patients. Taken
with permission from Difficult Airway Society (DAS) 2015 guidelines [45].
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i.e. The scalpel bougie-tube technique as using high flow oxygen could generate
aerosols and contamination [46], Front neck kit should be available immediately
in case needed however it is better keep nearby the room not inside to avoid
contaminate it.
8. Tracheostomy
A lot of COVID 19 patients need long time ventilation that many cases will
undergo tracheostomy, currently there is debate about the proper time case selec-
tion tracheostomy technique. The major indication for tracheostomy is to facilitate
mechanical ventilation for a long period, while reducing complications from a
trans-laryngeal endotracheal tube and weaning from ventilation. Airway obstruc-
tion, laryngeal oedema might be an emerging feature of COVID-19 which indicate
urgent tracheostomy [47, 48].
When elective tracheostomy is done, an inflated tracheostomy tube cuff via
which pressure support ventilation can be delivered affords a closed system for
controlled weaning of respiratory support.
Tracheostomy in COVID 19 patients is like intubation a high risk for aerosol
generating same consideration will apply for intuatbion however based on recent
reports for tracheostomised COVID 19 patients it is recommended to use of enhanced
PPE, with PAPRs(powered air-purifying respirators), eye protection, fluid-repellent
disposable surgical gown, and gloves If a PAPR is not available, we advise the use of a
fit-tested filtering face piece 3 (FFP3) or N95 mask with an additional fluid shield,
minimizing number of people during the procedure is necessary.
Surgical tracheostomies were generally favored over percutaneous tracheosto-
mies during the SARS outbreak, however, percutaneous techniques have subse-
quently advanced and no data are available to establish superiority of one approach
over the other from the standpoint of infectious transmission or safety. Single-use
bronchoscopes with a sealed ventilator circuit are preferable when doing percuta-
neous tracheostomies.
Good sedation should ensure during the procedure to avoid cough and muscle
relaxant might be used.
9. Extubation
Like intubation, extubation is an aerosol generating procedure (AGPs) and need
special attention in COVID 19 patients.
Specific considerations during extubation include [49]:
i. Strategies for supporting respiration after extubation, such as noninvasive
ventilation (NIV) and high-flow nasal oxygen (HFNC), are relatively
contraindicated because of their ability to aerosolize SARS-CoV-2
ii. Extubation should ideally take place in a negative pressure room, if
available.
iii. All non-essential staff should exit the room before extubation.
iv. Personal protective equipment (PPE) with airborne precautions is required
during extubation and for personnel entering the room for a variable period
of time after extubation, dependent on room ventilation.
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v. Limit the need for subsequent staff interactions with:
• Prophylactic and anti-emetics.
• Adequate analgesia; consider regional anesthesia. (What kind of
regional anesthesia for extubation? If it is an advice for surgery it
should take place above???)
vi. Perform oropharyngeal suction with vigilance, as this may generate
aerosols.
vii. Antitussive drugs, such as Remifentanil, Lidocaine, and Dexmedetomidine,
reduce the risk of coughing and minimize agitation on extubation.
Ensure good sedation before extubation. Efforts to prevent cough during
extubation should be implanted including possible use of medications like
Dexmedetomidine, Lidocaine, and/or opioids if there is no contraindication.
10. Extubation technique
Many techniques have been described to minimize exposure to aerosols during
extubation although no clear evidence behind them [50].
• Extubation under plastic cover
• Mask over tube technique with attached filter
• Extubation with LMA as alternative to ETT (contraindicated; as it can generate
aerosol and contact contamination,
• Extubation with lightweight barrier hood device [51]
10.1 Endotracheal tube exchange
On the ICU there are times the ETT may need to be changed, either due to
blockage or damage to the cuff. This is usually done with a tube exchanger, with the
new ETT railroaded over the bougie. The lungs of a COVID-19 patient are diseased
and more prone to trauma. It is advised to avoid blindly introducing a bougie into
the trachea with the possibility of advancing it too deep, and thus damaging the
airways, with a potential to cause a pneumothorax. If the airway is not predicted to
be difficult, paralyzing the patient, preoxygenation, extubation and then
reintubation with a fresh ETT using a video-laryngoscope would be the gentler way
to do it.
11. Single vs. reusable equipment during COVID19 outbreak
• Ideally single use equipment is the best option in such a huge pandemic like
COVID 19 pandemic, however because of the high transmission rate, applying
this does not look practical especially with enormous number of infected
people. It is really advised to avoid reusable equipment that will guarantee
15
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patient and health care provider safety as well. Actually, this fact utmost true
when invasive equipment is used [52, 53].
• As a general rule any non-invasive equipment contaminated with patient
secretions (blood, urine, vomit, or faces) or has been used with contact in
suspected or confirmed COVID 19 patients must decontaminated with,1,000
parts per million available chlorine (ppm av. cl) [54]
• The real concern in single use equipment is shortage of these devices, and in
highly demand situation replacement will be quite difficult.
• If re-usable equipment has been used special consideration should be taken in
decontamination process following local and manufacture recommendation is
a must.
12. Conclusion
Managing the airway in a patient who is potentially infective with a
droplet infection needs thorough understanding of the disease process and the
modifications to airway management technique, that have been seen to reduce
harm to the patients and reduce spread to the airway operators. The COVID 19
pandemic has taught us better ways to manage the airway, which can be used in all
aerosol generating procedures. Formulating a plan early with good preparation
and using checklists, meticulous patient assessment, personal protection for
staff, modification of technique and good after care are the cornerstones to achiev-
ing safe airway management in COVID19 patients and all AGPs in general.
(Best Practice Recommendations) Airway Management in Patient with
Suspected Novel Coronavirus (COVID19): Permission from Qatar Difficult
Airway Society (QMAD) (Figure 6)
Keep in your mind YOUR personal protection is the priority.
1.Please review the material and use droplet/contact isolation precautions
(PPE – face mask, long-sleeved gown, gloves, overhead, overshoes
with eye protection and fit-tested particulate respirators (N95 or
equivalent, or higher level of protection) when interacting with patients’
blood, body fluids, secretions (including respiratory secretions) and non-
intact skin.
2.Standard precautions should always be routinely applied in all areas of
health care facilities. Standard precautions include: hand hygiene;
prevention of needle-stick or sharps injury; safe waste management;
cleaning and disinfection of equipment; and cleaning of the environment.
3.Before intubation, review and practice wearing and removing the protective
barrier mask, gloves and clothing of the infected patient. Pay close attention
to avoid self-contamination.
4.Most skilled anesthetists available to perform suitable airway management
technique, if possible. Avoid junior intubation for sick patients.
5.Check carefully the followings; standard ASA monitoring, I.V. access,
equipment, drugs, ventilator and suction.
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6.Avoid awake fiberoptic intubation unless highly indicated. Atomized local
anesthetic will aerosolize the virus. Consider disposable videolaryngoscopes.
7.Plan for rapid sequence intubation and intubation (RSII) and ensure skilled
assistant able to perform cricoid pressure if needed. RSI may need to be
modified, if patient has very high alveolar-arterial gradient and is unable to
tolerate short period of apnea or has a contraindication to succinylcholine. If
manual ventilation is predicted, small tidal volumes should be applied.
Figure 6.
Qatar difficult airway society (QMAD)airway management in COVOD 19 patients.
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8.Three to five minutes of preoxygenation with oxygen 100% and RSI in order
to avoid manual ventilation of patient’s lungs and potential aerosolization of
virus from airways.
9.Avoid THRIVE/HFNC because will aerosolize the virus and spread the
infection inside and outside patient’s airway.
10.Ensure high efficiency hydrophobic filter interposed between facemask and
breathing circuit or between facemask and self-inflating (Ambo) bag.
11.After intubation; confirm correct position of tracheal tube.
12.Start mechanical ventilation and stabilize your patient.
13.All airway equipment must be sealed in double zip-locked plastic bag and
removed for decontamination and disinfection.
14.Assigned personnel should then wipe down surfaces with appropriate
disinfectant (as directed by our hospital infection control policy) after exiting
the negative-pressure atmosphere.
15.After removing your PPE, avoid touching your hair or face before washing
hands.
16.Hospital infection control department will provide additional updates
regarding the management of patients at the various hospital facilities.
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